Active Ingredient(s):Adalimumab-adaz FDA Approved: * October 30, 2018 Pharm Company: *SANDOZ INC Category:Immunosuppressive
Adalimumab, sold under the brand name Humira, among others, is a monoclonal antibody used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis. It is administered by injection under the skin.
Common side effects include upper respiratory tract infections, pain at the site o...
* May have multiple approval dates, manufacturers, or labelers.